Skip to content

Clinical trials

Phase 2/3 Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2/3 Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20081
20091
20101
20111
20121
20131
20143
20151
20173
20183
20221
20231
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated7
Recruiting6
Active, not recruiting5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
AbbVie2
Ann & Robert H Lurie Children's Hospital of Chicago2
ASLAN Pharmaceuticals1
Amgen1
Bristol-Myers Squibb1
CG Oncology, Inc.1
CatalYm GmbH1
Celgene1
Clovis Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms31
Fatigue6
Neoplasm Metastasis4
Leukemia3
Recurrence3
Anorexia2
Cachexia2
Carcinoma, Non-Small-Cell Lung2
Leukemia, Myeloid, Acute2
Pancreatic Neoplasms2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.